Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 GILD | Gilead Sciences Inc | $160.4b | $130.20 | +0.5% | 2.6M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 NTLA | Intellia Therapeutics, Inc | $1.6b | $12.40 | -9.3% | 5.5M |
 IMTX | Immatics N.V. Ordinary Shares | $1.6b | $10.53 | -3.1% | 218.7K |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.4b | $3.46 | +0.1% | 5.6M |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $3.04 | -1.1% | 1.6M |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.8b | $1.98 | -1.3% | 3.0M |
 VOR | Vor Biopharma Inc. Common Stock | $0.7b | $14.40 | -1.6% | 385.2K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $0.5b | $16.94 | -5.5% | 55.0K |
 ENGN | enGene Therapeutics Inc. Common Stock | $466.2m | $1.56 | -9.0% | 1.1M |
 IMMX | Immix Biopharma, Inc. Common Stock | $455.9m | $9.26 | -6.9% | 311.4K |
 IPSC | Century Therapeutics, Inc. Common Stock | $396.8m | $2.27 | -3.2% | 877.9K |
 YDES | YD Bio Limited Ordinary Shares | $366.7m | $4.87 | -6.0% | 1.4K |
 TARA | Protara Therapeutics, Inc. Common Stock | $277.5m | $4.61 | -9.7% | 583.4K |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $224.2m | $9.13 | -6.7% | 386.1K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $205.3m | $2.04 | -4.4% | 1.3M |
 NKTX | Nkarta, Inc. Common Stock | $197.5m | $2.69 | +2.1% | 488.3K |
 FATE | Fate Therapeutics, Inc. | $151.2m | $1.73 | -1.7% | 1.6M |
 ANIX | Anixa Biosciences, Inc. | $100.9m | $2.77 | -1.6% | 84.6K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $75.7m | $1.00 | +0.4% | 337.2K |
 ACET | Adicet Bio, Inc. Common Stock | $73.6m | $7.42 | -3.5% | 53.9K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $65.3m | $1.12 | +0.9% | 19.1K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $54.0m | $10.19 | -4.9% | 15.2K |
 ATRA | Atara Biotherapeutics, Inc | $40.3m | $9.36 | -2.3% | 254.8K |
 CELU | Celularity Inc. Class A Common Stock | $30.0m | $0.80 | -1.1% | 34.9K |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $29.8m | $0.95 | -5.5% | 202.7K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $27.0m | $8.84 | +11.2% | 10.0K |
 INAB | IN8bio, Inc. Common Stock | $15.1m | $1.41 | -5.4% | 61.9K |
 LNAI | Lunai Bioworks Inc. Common Stock | $12.3m | $0.27 | +4.2% | 789.3K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $10.6m | $1.24 | +6.5% | 113.0K |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $8.2m | $0.78 | -2.8% | 105.3K |
 MBIO | Mustang Bio, Inc. | $5.7m | $0.59 | -2.6% | 78.9K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $5.6m | $12.20 | -10.6% | 196.6K |
 CLDI | Calidi Biotherapeutics, Inc. | $2.4m | $0.18 | -1.4% | 735.3K |